References
- Ahn JH, Choi YS, Choi JH. 2015. Leptin promotes human endometriotic cell migration and invasion by up-regulating MMP2 through the JAK2/STAT3 signaling pathway. Mol Hum Reprod. 21:792–802. doi: https://doi.org/10.1093/molehr/gav039
- Arimoto T, Katagiri T, Oda K, Tsunoda T, Yasugi T, et al. 2003. Genome-wide cDNA microarray analysis of gene-expression profiles involved in ovarian endometriosis. Int J Oncol. 22:551–560.
- Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–297. doi: https://doi.org/10.1016/S0092-8674(04)00045-5
- Burney RO, Hamilton AE, Aghajanova L, Vo KC, Nezhat CN, et al. 2009. MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis. Mol Hum Reprod. 15:625–631. doi: https://doi.org/10.1093/molehr/gap068
- Chen J, Gu L, Ni J, Hu P, Hu K, et al. 2015. MiR-183 regulates ITGB1P expression and promotes invasion of endometrial stromal cells. BioMed Res Int. 2015:340218.
- Chen X, Lu P, Chen L, Yang SJ, Shen HY, et al. 2015. Perioperative propofol-paravertebral anesthesia decreases the metastasis and progression of breast cancer. Tumour Biol. 36:8259–8266. doi: https://doi.org/10.1007/s13277-015-4027-5
- Dai L, Gu L, Di W. 2012. MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKβ/NF-κB pathway and reduced interleukin-8 expression. Mol Hum Reprod. 18:136–145. doi: https://doi.org/10.1093/molehr/gar066
- Fabregat I, Fernando J, Mainez J, Sancho P. 2014. TGF-beta signaling in cancer treatment. Curr Pharm Des. 20:2934–2947. doi: https://doi.org/10.2174/13816128113199990591
- Feng S, Sun Y. 2018. Protective role of propofol in endometriosis and its mechanism. Exp Ther Med. 16:3646–3650.
- Freeman J, Crowley PD, Foley AG, Gallagher HC, Iwasaki M, et al. 2019. Effect of perioperative lidocaine, propofol and steroids on pulmonary metastasis in a murine model of breast cancer surgery. Cancers (Basel). 11:613. doi: https://doi.org/10.3390/cancers11050613
- Guan YT, Huang YQ, Wu JB, Deng ZQ, Wang Y, et al. 2016. Overexpression of chloride channel-3 is associated with the increased migration and invasion ability of ectopic endometrial cells from patients with endometriosis. Hum Reprod. 31:986–998. doi: https://doi.org/10.1093/humrep/dew034
- Guo SK, Shen MF, Yao HW, Liu YS. 2018. Enhanced expression of TGFBI promotes the proliferation and migration of glioma cells. Cell Physiol Biochem. 49:1097–1109. doi: https://doi.org/10.1159/000493293
- Hao W, Zhao ZH, Meng QT, Tie ME, Lei SQ, et al. 2017. Propofol protects against hepatic ischemia/reperfusion injury via miR-133a-5p regulating the expression of MAPK6. Cell Biol Int. 41:495–504. doi: https://doi.org/10.1002/cbin.10745
- Huang X, Teng Y, Yang H, Ma J. 2016. Propofol inhibits invasion and growth of ovarian cancer cells via regulating miR-9/NF-κB signal. Braz J Med Biol Res. 49:e5717. doi: https://doi.org/10.1590/1414-431x20165717
- Kim R. 2018. Effects of surgery and anesthetic choice on immunosuppression and cancer recurrence. J Transl Med. 16:8. doi: https://doi.org/10.1186/s12967-018-1389-7
- Lindsay SF, Luciano DE, Luciano AA. 2015. Emerging therapy for endometriosis. Expert Opin Emerg Drugs. 20:449–461. doi: https://doi.org/10.1517/14728214.2015.1051966
- Liu S, Gao S, Wang XY, Wang DB. 2012. Expression of miR-126 and Crk in endometriosis: miR-126 may affect the progression of endometriosis by regulating Crk expression. Arch Gynecol Obstet. 285:1065–1072. doi: https://doi.org/10.1007/s00404-011-2112-6
- Liu H, Zhang Z, Xiong W, Zhang L, Xiong Y, et al. 2017. Hypoxia-inducible factor-1alpha promotes endometrial stromal cells migration and invasion by upregulating autophagy in endometriosis. Reproduction. 153:809–820. doi: https://doi.org/10.1530/REP-16-0643
- Maheshwari A, Gurunath S, Fatima F, Bhattacharya S. 2012. Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes. Hum Reprod Update. 18:374–392. doi: https://doi.org/10.1093/humupd/dms006
- Nothnick WB. 2017. MicroRNAs and endometriosis: distinguishing drivers from passengers in disease pathogenesis. Semin Reprod Med. 35:173–180. doi: https://doi.org/10.1055/s-0037-1599089
- Nyholt DR, Low SK, Anderson CA, Painter JN, Uno S, et al. 2012. Genomewide association metaanalysis identifies new endometriosis risk loci. Nat Genet. 44:1355–1359. doi: https://doi.org/10.1038/ng.2445
- Painter JN, Anderson CA, Nyholt DR, Macgregor S, Lin J, et al. 2011. Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat Genet. 43:51–54. doi: https://doi.org/10.1038/ng.731
- Schonrock N, Humphreys DT, Preiss T, Götz J. 2012. Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-β. J Mol Neurosci. 46:3243–3235. doi: https://doi.org/10.1007/s12031-011-9587-2
- Schrager S, Falleroni J, Edgoose J. 2013. Evaluation and treatment of endometriosis. Am Fam Physician. 87:107–113.
- Shang D, Liu Y, Yang P, Chen Y, Tian Y. 2012. TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel-Lindau tumor suppressor. Urology. 79:966–e1-7. doi: https://doi.org/10.1016/j.urology.2011.12.011
- Sun H, Gao D. 2018. Propofol suppresses growth, migration and invasion of A549 cells by down-regulation of miR-372. BMC Cancer. 18:1252. doi: https://doi.org/10.1186/s12885-018-5175-y
- Vasileiou I, Xanthos T, Koudouna E, Perrea D, Klonaris C, et al. 2009. Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol. 605:1–8. doi: https://doi.org/10.1016/j.ejphar.2009.01.007
- Vercellini P, Viganò P, Somigliana E, Fedele L. 2014. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 10:261–275. doi: https://doi.org/10.1038/nrendo.2013.255
- Wang BJ, Chi KP, Shen RL, Zheng SW, Guo Y, et al. 2019. TGFBI promotes tumor growth and is associated with poor prognosis in oral squamous cell carcinoma. J Cancer. 10:4902–4912. doi: https://doi.org/10.7150/jca.29958
- Xie F, Ling L, van Dam H, Zhou F, Zhang L. 2018. TGF-β signaling in cancer metastasis. Acta Biochim Biophys Sin (Shanghai). 50:121–132. doi: https://doi.org/10.1093/abbs/gmx123
- Xu K, Tao W, Su Z. 2018. Propofol prevents IL-13-induced epithelial-mesenchymal transition in human colorectal cancer cells. Cell Biol Int. 42:985–993. doi: https://doi.org/10.1002/cbin.10964
- Xu H, Yang JJ, Wang CH, Guo EY, Yang NH, et al. 2016. Effect of Wnt/β-catenin signal pathway on matrix metalloproteinase-7 and vascular endothelial growth factor gene expressions in endometriosis. Clin Exp Obstet Gynecol. 43:573–577.
- Yang N, Liang Y, Yang P, Ji F. 2017. Propofol suppresses LPS-induced nuclear accumulation of HIF-1α and tumor aggressiveness in non-small cell lung cancer. Oncol Rep. 37:2611–2619. doi: https://doi.org/10.3892/or.2017.5514
- Zheng X, Huang H, Liu J, Li M, Liu M, et al. 2018. Propofol attenuates inflammatory response in LPS-activated microglia by regulating the miR-155/SOCS1 pathway. Inflammation. 4:11–19. doi: https://doi.org/10.1007/s10753-017-0658-6
- Zheng Q, Xu Y, Lu J, Zhao J, Wei X, et al. 2016. Emodin inhibits migration and invasion of human endometrial stromal cells by facilitating the mesenchymal-epithelial transition through targeting ILK. Reprod Sci. 23:1526–1535. doi: https://doi.org/10.1177/1933719116645192